AU2022319598A1 - Novel spiropyrrolidine derived antiviral agents - Google Patents

Novel spiropyrrolidine derived antiviral agents Download PDF

Info

Publication number
AU2022319598A1
AU2022319598A1 AU2022319598A AU2022319598A AU2022319598A1 AU 2022319598 A1 AU2022319598 A1 AU 2022319598A1 AU 2022319598 A AU2022319598 A AU 2022319598A AU 2022319598 A AU2022319598 A AU 2022319598A AU 2022319598 A1 AU2022319598 A1 AU 2022319598A1
Authority
AU
Australia
Prior art keywords
optionally substituted
compound
mmol
pharmaceutically acceptable
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022319598A
Other languages
English (en)
Inventor
Samuel Bartlett
Hui Cao
Yong He
Wei Li
Yat Sun Or
Joseph D. PANARESE
Xiaowen Peng
Matthew C. RHODES
Ruichao Shen
Guoqiang Wang
Xuechao Xing
Jiajun Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enanta Pharmaceuticals Inc
Original Assignee
Enanta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/479,248 external-priority patent/US11325916B1/en
Application filed by Enanta Pharmaceuticals Inc filed Critical Enanta Pharmaceuticals Inc
Publication of AU2022319598A1 publication Critical patent/AU2022319598A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2022319598A 2021-07-29 2022-04-14 Novel spiropyrrolidine derived antiviral agents Pending AU2022319598A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163227206P 2021-07-29 2021-07-29
US63/227,206 2021-07-29
US17/479,248 2021-09-20
US17/479,248 US11325916B1 (en) 2021-07-29 2021-09-20 Spiropyrrolidine derived antiviral agents
US202263324367P 2022-03-28 2022-03-28
US63/324,367 2022-03-28
PCT/US2022/024772 WO2023009187A1 (en) 2021-07-29 2022-04-14 Novel spiropyrrolidine derived antiviral agents

Publications (1)

Publication Number Publication Date
AU2022319598A1 true AU2022319598A1 (en) 2024-02-08

Family

ID=85087186

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022319598A Pending AU2022319598A1 (en) 2021-07-29 2022-04-14 Novel spiropyrrolidine derived antiviral agents

Country Status (8)

Country Link
EP (1) EP4376834A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024529476A (cg-RX-API-DMAC7.html)
KR (1) KR20240044452A (cg-RX-API-DMAC7.html)
AU (1) AU2022319598A1 (cg-RX-API-DMAC7.html)
CA (1) CA3173702A1 (cg-RX-API-DMAC7.html)
IL (1) IL310246A (cg-RX-API-DMAC7.html)
MX (1) MX2024001377A (cg-RX-API-DMAC7.html)
WO (1) WO2023009187A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7559223B2 (ja) 2020-08-24 2024-10-01 ギリアード サイエンシーズ, インコーポレイテッド リン脂質化合物及びその使用
TWI925033B (zh) 2020-10-16 2026-05-11 美商基利科學股份有限公司 磷脂化合物及其用途
WO2023283256A1 (en) 2021-07-09 2023-01-12 Aligos Therapeutics, Inc. Anti-viral compounds
AU2023303408A1 (en) 2022-07-06 2024-12-19 Aligos Therapeutics, Inc. Anti-viral compounds
EP4612156A1 (en) * 2022-11-02 2025-09-10 Aligos Therapeutics, Inc. Anti-viral compounds
CN119139307B (zh) * 2023-12-29 2025-09-23 上海柯君医药科技有限公司 螺环类化合物在制备3CLpro蛋白酶抑制剂或药物中的用途
WO2025221657A1 (en) * 2024-04-15 2025-10-23 Aligos Therapeutics, Inc. Anti-viral compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061714A2 (en) * 2004-12-09 2006-06-15 Pfizer Inc. Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
US8222288B2 (en) * 2006-08-30 2012-07-17 The Regents Of The University Of Michigan Small molecule inhibitors of MDM2 and the uses thereof
CA2661354C (en) * 2006-08-30 2012-12-18 The Regents Of The University Of Michigan New small molecule inhibitors of mdm2 and the uses thereof
US8575208B2 (en) * 2007-02-27 2013-11-05 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
UY37381A (es) * 2016-08-30 2018-03-23 Glaxosmithkline Ip No 2 Ltd Compuestos que inhiben proteasas 3c y 3cl y métodos de uso de los mismos
US12398147B2 (en) * 2021-05-11 2025-08-26 Enanta Pharmaceuticals, Inc. Macrocyclic spiropyrrolidine derived antiviral agents
US11325916B1 (en) * 2021-07-29 2022-05-10 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
WO2023086400A1 (en) * 2021-11-12 2023-05-19 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
WO2023125825A1 (en) * 2021-12-29 2023-07-06 Shanghai Curegene Pharmaceutical Co., Ltd. Anticoronviral compounds and compositions and uses thereof

Also Published As

Publication number Publication date
KR20240044452A (ko) 2024-04-04
EP4376834A4 (en) 2025-06-18
WO2023009187A1 (en) 2023-02-02
EP4376834A1 (en) 2024-06-05
CA3173702A1 (en) 2023-01-29
IL310246A (en) 2024-03-01
JP2024529476A (ja) 2024-08-06
MX2024001377A (es) 2024-03-08

Similar Documents

Publication Publication Date Title
US12479854B2 (en) Spiropyrrolidine derived antiviral agents
AU2021313130A1 (en) Functionalized peptides as antiviral agents
US12540141B2 (en) Spiropyrrolidine derived antiviral agents
US12145942B2 (en) Spiropyrrolidine derived antiviral agents
WO2023009187A1 (en) Novel spiropyrrolidine derived antiviral agents
WO2022109363A1 (en) Novel spiropyrrolidine derived antiviral agents
WO2022109360A1 (en) Novel spiropyrrolidine derived antiviral agents
US11919910B2 (en) Spiropyrrolidine derived antiviral agents
WO2022036018A1 (en) Functionalized peptides as antiviral agents
WO2023091561A1 (en) Novel spiropyrrolidine derived antiviral agents
WO2023086350A1 (en) Alkyne-containing antiviral agents
WO2023086352A1 (en) Novel spiropyrrolidine derived antiviral agents
WO2023107419A1 (en) Saturated spirocyclics as antiviral agents
US20230115107A1 (en) Novel spiropyrrolidine derived antiviral agents
US12145941B2 (en) Heterocyclic antiviral agents
WO2023003610A1 (en) Novel spiropyrrolidine derived antiviral agents
WO2023211997A1 (en) Antiviral compounds
WO2022240541A1 (en) Novel macrocyclic spiropyrrolidine derived antiviral agents
EA050743B1 (ru) Новые противовирусные агенты на основе производных спиропирролидина
HK40071048A (en) Novel spiropyrrolidine derived antiviral agents
CN118043045A (zh) 新型螺吡咯烷衍生的抗病毒药物